Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0275389 NOVEL GLYCAN CONJUGATES AND USE THEREOF
This disclosure includes an immunogenic composition containing (a) a glycan conjugate including a carrier and one or more glycans, wherein each of the one or...
2017/0275388 FRACTIONATED ALKYLATED CYCLODEXTRIN COMPOSITIONS AND PROCESSES FOR PREPARING AND USING THE SAME
The present invention relates to compositions comprising fractionated alkylated cyclodextrm compositions having a single degree of substitution, and processes...
2017/0275387 DEXTRIN COPOLYMER WITH STYRENE AND AN ACRYLIC ESTER, MANUFACTURING METHOD THEREOF, AND USE THEREOF FOR PAPER...
Disclosed is a copolymer of a dextrin and at least two hydrophobic monomers made up of styrene and at least one straight or branched acrylic C1-C4 ester. The...
2017/0275386 Milling Process
The present invention provides process for treating crop kernels, comprising the steps of a) soaking kernels in water to produce soaked kernels; b) grinding...
2017/0275385 CELLULOSE-CONTAINING COMPOSITIONS AND METHODS OF MAKING SAME
Cellulose-containing compositions and method of making same are disclosed. The compositions comprise a cellulose product comprising a type-I cellulose, a...
2017/0275384 ADHESIVE COMPOSITIONS COMPRISING TYPE-II CELLULOSE
Admixtures comprising an adhesive resin and cellulose are disclosed, in which at least a portion of the cellulose is type-II cellulose. Also disclosed are...
2017/0275383 RESIN COMPOSITION, RESIN MOLDED ARTICLE, AND METHOD OF PREPARING RESIN COMPOSITION
A resin composition includes a cellulose derivative in which at least one hydroxyl group is substituted with an acyl group, which has a weight average...
2017/0275382 MULTIVALENT CD20-BINDING MOLECULE COMPRISING SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES AND ENRICHED...
The present invention provides multivalent CD20-binding molecules, and compositions thereof, such as enriched compositions comprising large proportions of...
2017/0275381 DETECTION OF A POSTTRANSLATIONALLY MODIFIED POLYPEPTIDE BY A BIVALENT BINDING AGENT
A bivalent binding agent having a first monovalent binder that binds to a polypeptide epitope of a target polypeptide, a second monovalent binder that binds to...
2017/0275380 DETECTION OF A POLYPEPTIDE DIMER BY A BIVALENT BINDING AGENT
A bivalent binding agent, capable of binding a polypeptide dimer, consisting of two monovalent binders linked to each other via a linker, the first monovalent...
2017/0275379 TREATMENT OF OTITIS MEDIA
A method of treating otitis media in a subject is described that includes administering to the subject a therapeutically effective amount of an Actin-Related...
2017/0275378 MONOCLONAL ANTIBODY, INHIBITING THE ENZYMATIC ACTIVITY OF VASCULAR ENDOTHELIAL LIPASE
Provided is a monoclonal antibody or a fragment thereof that selectively inhibits the enzymatic activity of vascular endothelial lipase and pharmaceutical...
2017/0275377 ANTIBODIES AND MOLECULES DERIVED THEREFROM THAT BIND TO STEAP-1 PROTEINS
Antibodies and molecules derived therefrom that bind to novel STEAP-1 protein, and variants thereof, are described wherein STEAP-1 exhibits tissue specific...
2017/0275376 ANTIBODY CAPABLE OF NEUTRALIZING SUBSTANCE HAVING ACTIVITY ALTERNATIVE TO FUNCTION OF COAGULATION FACTOR VIII...
The present inventors attempted to produce antibodies that neutralize the activity of a substance having an activity of functionally substituting for FVIII to...
2017/0275375 COMBINATION THERAPY WITH T-CELL REDIRECTING BISPECIFIC ANTIBODIES AND CHECKPOINT INHIBITORS
The present invention concerns compositions and methods of use of bispecific antibodies comprising at least one binding site for a tumor-associated antigen...
2017/0275374 TROPHOBLAST GLYCOPROTEIN (5T4, TPBG) SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNOTHERAPY
The present invention relates to Chimeric Antigen Receptors (CAR) that are recombinant chimeric proteins able to redirect immune cell specificity and...
2017/0275373 BISPECIFIC SINGLE CHAIN ANTIBODY CONSTRUCT WITH ENHANCED TISSUE DISTRIBUTION
The present invention provides to a bispecific single chain antibody construct binding to a target cell surface antigen via a first binding domain and to the T...
2017/0275372 ANTIBODIES DIRECTED AGAINST ICOS FOR TREATING GRAFT-VERSUS-HOST DISEASE
The invention relates to a specific antibody directed against, for use for treating graft versus host disease.
2017/0275371 Methods Of Treatment
Disclosed herein are combinations of an OX40 modulator and a TLR4 modulator, pharmaceutical compositions thereof, uses thereof, and methods of treatment...
2017/0275370 METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE...
Methods of treating metabolic diseases and disorders using an antigen binding protein specific for the GIPR polypeptide are provided. In various embodiments...
2017/0275369 METHODS OF TREATING SKIN DISORDERS USING ANTI-IL-31RA ANTIBODIES
The present invention relates to methods of treating patients suffering from Contact dermatitis, Drug induced delayed type cutaneous allergic reactions, Toxic...
2017/0275368 ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF
The present invention relates to antibodies against human CSF-1R (CSF-1R antibody), methods for their production, pharmaceutical compositions containing said...
2017/0275367 Bispecific EGFR/C-Met Antibodies
Bispecific EGFR/c-Met antibodies and methods of making and using the molecules.
2017/0275365 ALPHA-4-BETA-7 HETERODIMER SPECIFIC ANTAGONIST ANTIBODY
There are disclosed alpha4beta7 heterodimer-specific antigen binding proteins, nucleic acids encoding them, and methods of making and using them.
2017/0275364 Compositions and Methods to Enhance the Immune System
The invention relates to the field of molecular medicine. In particular, it relates to compositions and methods to enhance the clearance of aberrant cells,...
2017/0275363 HUMANIZED ANTI-CD22 ANTIBODY
Disclosed are humanized RFB4 antibodies or antigen-binding fragments thereof. therapy of B-cell associated diseases, such as B-cell malignancies, autoimmune...
2017/0275362 CHIMERIC ANTIGEN RECEPTORS TARGETING FC RECEPTOR-LIKE 5 AND USES THEREOF
The presently disclosed subject matter provides for methods and compositions for treating a neoplasia (e.g., multiple myeloma). It relates to chimeric antigen...
2017/0275361 TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING...
This invention provides, and in certain specific but non-limiting aspects relates to: --assays that can be used to predict whether a given ISV will be subject...
2017/0275360 TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING...
This invention provides, and in certain specific but non-limiting aspects relates to: --assays that can be used to predict whether a given ISV will be subject...
2017/0275359 ANTI-EPHRINB2 ANTIBODIES AND METHODS USING SAME
The invention provides anti-EphrinB2 antibodies, and compositions comprising and methods of using these antibodies.
2017/0275358 Use of IL-1 Binding Antibodies
The present invention relates to an IL-1.beta. binding antibody or a functional fragment thereof for use in preventing or reducing risk of experiencing a...
2017/0275357 IL-23p19 MONOCLONAL ANTIBODIES AND METHODS OF USING THE SAME
The present invention relates to antagonizing the activity of IL-17A, IL-17F and IL-23 using bispecific antibodies that comprise a binding entity that is...
2017/0275356 ANTIBODIES THAT BIND IL-23
The present invention provides an antibody that binds to the p19 subunit of human IL-23 and is characterized as having high affinity, selective, and...
2017/0275355 NEUTRALISING ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN IL-17
The invention relates to an antibody molecule having specificity for antigenic determinants of IL-17, therapeutic uses of the antibody molecule and methods for...
2017/0275354 ANTIBODIES TO M-CSF
The present invention relates to antibodies and antigen-binding portions thereof that specifically bind to a M-CSF, preferably human M-CSF, and that function...
2017/0275353 TRISPECIFIC INHIBITORS FOR CANCER TREATMENT
A trispecific inhibitor for treating cancer includes a first targeting domain having a binding specificity conferred by a VEGF binding antagonist; a second...
2017/0275352 Methods of Treating Chronic Pain
The invention relates to an anti-CGRP antibody for use in the prevention and/or treatment of chronic pain and/or symptoms of chronic pain, and to a method of...
2017/0275351 METHOD FOR PRODUCTION OF ANTIBODY
The present invention provides a method of producing a recombinant antibody efficiently and at low cost. Disclosed is a method of producing an antibody or a...
2017/0275350 Protease Activated Receptor-1 (PAR1) Derived Cytoprotective Polypeptides and Related Methods
The present invention provides novel PAR1 derived cytoprotective oligopeptides or polypeptides which typically contain at least the first 4 N-terminal residues...
2017/0275349 RECOMBINANT CHICKEN INTERLEUKIN-1 BETA PROTEIN FOR PRODUCING ANTIBODY EARLY AND RETAINING FOR A LONGER PERIOD...
The present invention provides a recombinant chicken interleukin-1.beta. protein for producing antibody early and retaining for a longer period of time, which...
2017/0275348 HOMOGENEOUS PREPARATIONS OF IL-31
Homogeneous preparations of human and murine IL-31 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding...
2017/0275347 METHODS FOR IDENTIFYING PATIENTS RESPONSIVE TO ANTI-PD-L1 ANTIBODY THERAPY
The disclosure provides methods for treating lung cancer (e.g., non-small cell lung cancer) with an anti-PD-L1 antibody in a patient identified using a...
2017/0275346 METHOD FOR FORMING A REVERSIBLE PROTEIN NANOCLUSTER USING LIGHT IN A CELL
To efficiently analyze interaction and function between proteins, the present invention relates to a method for forming a light-induced protein nanocluster,...
2017/0275345 COLLAGEN-BINDING SYNTHETIC PEPTIDOGLYCANS, PREPARATION, AND METHODS OF USE
This invention relates to collagen-binding synthetic peptidoglycans and engineered collagen matrices comprising a collagen matrix and a collagen-binding...
2017/0275344 POLYPEPTIDES AND USES THEREOF AS A DRUG FOR TREATMENT OF AUTOIMMUNE DISORDERS
This invention, in at least some embodiments, relates to a protein C1ORF32 and its variants and fragments and fusion proteins thereof, and methods of use...
2017/0275343 COMPOSITIONS AND METHODS FOR MAKING WATER-SOLUBLE INTEGRAL MEMBRANE PROTEINS
The present invention relates to a nucleic acid construct having a chimeric nucleic acid molecule comprising a first nucleic acid moiety encoding an...
2017/0275342 PROTEIN SCAFFOLDS FOR ANTIBODY MIMICS AND OTHER BINDING PROTEINS
Disclosed herein are proteins that include an immunoglobulin fold and that can be used as scaffolds. Also disclosed herein are nucleic acids encoding such...
2017/0275341 UBIQUITIN VARIANT MODULATORS OF HECT E3 LIGASES AND THEIR USES
The invention provides ubiquitin variants that specifically bind to HECT E3 ligases, and methods of using these variants to modulate the activity of HECT E3...
2017/0275340 ANTI-CANCER COMPOSITIONS CONTAINING WNT DECOY RECEPTOR
The present invention relates to a composition for preventing or treating cancer comprising Wnt decoy receptor. The composition of the present invention or the...
2017/0275339 HERPES SIMPLEX VIRUS VACCINE
Herpes Simplex Virus (HSV) antigens that elicit an HSV-specific immune response and can be used to treat or prevent HSV infection are provided. Nucleic acid...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.